Center for Immunology and Microbial Disease, Albany Medical College, Albany, New York, United States of America.
PLoS One. 2012;7(1):e30939. doi: 10.1371/journal.pone.0030939. Epub 2012 Jan 24.
The HIV1 protein Vpr assembles with and acts through an ubiquitin ligase complex that includes DDB1 and cullin 4 (CRL4) to cause G2 cell cycle arrest and to promote degradation of both uracil DNA glycosylase 2 (UNG2) and single-strand selective mono-functional uracil DNA glycosylase 1 (SMUG1). DCAF1, an adaptor protein, is required for Vpr-mediated G2 arrest through the ubiquitin ligase complex. In work described here, we used UNG2 as a model substrate to study how Vpr acts through the ubiquitin ligase complex. We examined whether DCAF1 is essential for Vpr-mediated degradation of UNG2 and SMUG1. We further investigated whether Vpr is required for recruiting substrates to the ubiquitin ligase or acts to enhance its function and whether this parallels Vpr-mediated G2 arrest.
METHODOLOGY/PRINCIPAL FINDINGS: We found that DCAF1 plays an important role in Vpr-independent UNG2 and SMUG1 depletion. UNG2 assembled with the ubiquitin ligase complex in the absence of Vpr, but Vpr enhanced this interaction. Further, Vpr-mediated enhancement of UNG2 degradation correlated with low Vpr expression levels. Vpr concentrations exceeding a threshold blocked UNG2 depletion and enhanced its accumulation in the cell nucleus. A similar dose-dependent trend was seen for Vpr-mediated cell cycle arrest.
CONCLUSIONS/SIGNIFICANCE: This work identifies UNG2 and SMUG1 as novel targets for CRL4(DCAF1)-mediated degradation. It further shows that Vpr enhances rather than enables the interaction between UNG2 and the ubiquitin ligase. Vpr augments CRL4(DCAF1)-mediated UNG2 degradation at low concentrations but antagonizes it at high concentrations, allowing nuclear accumulation of UNG2. Further, the protein that is targeted to cause G2 arrest behaves much like UNG2. Our findings provide the basis for determining whether the CRL4(DCAF1) complex is alone responsible for cell cycle-dependent UNG2 turnover and will also aid in establishing conditions necessary for the identification of additional targets of Vpr-enhanced degradation.
HIV1 蛋白 Vpr 与包括 DDB1 和 cullin 4 (CRL4) 的泛素连接酶复合物组装,并通过该复合物引起 G2 细胞周期停滞,并促进尿嘧啶 DNA 糖基化酶 2 (UNG2) 和单链选择性单功能尿嘧啶 DNA 糖基化酶 1 (SMUG1) 的降解。衔接蛋白 DCAF1 通过泛素连接酶复合物是 Vpr 介导的 G2 停滞所必需的。在本文描述的工作中,我们使用 UNG2 作为模型底物来研究 Vpr 如何通过泛素连接酶复合物发挥作用。我们检查了 DCAF1 是否是 Vpr 介导的 UNG2 和 SMUG1 降解所必需的。我们进一步研究了 Vpr 是否需要招募底物到泛素连接酶或作用以增强其功能,以及这是否与 Vpr 介导的 G2 停滞平行。
方法/主要发现:我们发现 DCAF1 在 Vpr 非依赖性 UNG2 和 SMUG1 耗竭中起重要作用。UNG2 与泛素连接酶复合物在没有 Vpr 的情况下组装,但 Vpr 增强了这种相互作用。此外,Vpr 介导的 UNG2 降解增强与低 Vpr 表达水平相关。Vpr 浓度超过阈值会阻止 UNG2 耗尽并增强其在细胞核中的积累。Vpr 介导的细胞周期停滞也出现了类似的剂量依赖性趋势。
结论/意义:这项工作将 UNG2 和 SMUG1 确定为 CRL4(DCAF1)介导的降解的新靶标。它进一步表明,Vpr 增强而不是使 UNG2 与泛素连接酶之间的相互作用。Vpr 在低浓度时增强 CRL4(DCAF1)介导的 UNG2 降解,但在高浓度时拮抗它,从而允许 UNG2 核内积累。此外,被靶向以引起 G2 停滞的蛋白质的行为与 UNG2 非常相似。我们的发现为确定 CRL4(DCAF1)复合物是否单独负责细胞周期依赖性 UNG2 周转提供了基础,并将有助于确定 Vpr 增强降解的其他靶标的必要条件。